Navigation Links
Pharmatek Announces Facility Expansion
Date:2/27/2013

SAN DIEGO, Feb. 27, 2013 /PRNewswire/ -- Pharmatek, a contract development and manufacturing organization supporting the pharmaceutical industry, announced plans to expand its GMP facilities. The expansion comes at a time when the Company is experiencing strong growth and increasing global demand for its services.

Projected for completion in the fourth quarter of 2013, the expansion includes three additional cGMP manufacturing suites, a new automated packaging line and further drug product and cold storage. The packaging line will produce batch sizes up to 10,000 bottles per day. The new facility is designed to handle highly potent and cytotoxic compounds, control humidity between 20% and 60% RH, and includes client manufacturing viewing areas.

"Matched with our recent equipment purchases, the addition of automated packaging and larger suites enables us to handle larger scale clinical trial material productions; providing a higher level of customer service," stated Kevin Rosenthal , director of manufacturing at Pharmatek. "The ability to serve our clients longer, as they advance their compounds down the development pipeline, reduces their overall costs and time-to-clinic."

The additional manufacturing space increases Pharmatek's production capacity by 50%.  A similar sized expansion is planned for 2014 to accommodate expected long-term growth of the Company's operations.

"This expansion plays an important role in our continuous efforts to meet our clients' needs and our ongoing efforts to broaden our manufacturing capabilities," said Tim Scott , president of Pharmatek. "As we move toward becoming a more fully integrated CMO at all phases of the development pipeline, we will continue to invest in new equipment and our facilities."

About Pharmatek Laboratories, Inc.        
Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development company providing full-service pharmaceutical chemistry product development and manufacturing for the pharmaceutical industry.  Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing, stability storage and testing, and cytotoxic and high-potency drug development.

Statements contained in this media release which are not historical facts may constitute forward-looking statements.  All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected including sales forecasts and strategic expansion.  The trademarks Pharmatek, Pharmatek Laboratories, Inc., Hot Rod Chemistry, Pharmatek Formulation Screening, Pharmatek University and PTEK U are all property of Pharmatek Laboratories, Inc.  Additional information about Pharmatek Laboratories may be obtained at the Web site http://www.pharmatek.com or by calling 858-805-6383.

Company Contact:
Kimberly Scholz , Marketing Associate
Pharmatek Laboratories, Inc.
(858) 805-6383 x 284
kscholz@pharmatek.com


'/>"/>
SOURCE Pharmatek
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmatek Establishes the Pharmatek Foundation
2. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
3. Sonitus Medical Announces Affirmative Update Regarding Bone Conduction Oral Appliances in American Academy of Otolaryngology-Head and Neck Surgery Policy Statement on Implantable Hearing Devices
4. AG Mednet Announces Cloud Storage Solution with On-Demand Access to Clinical Trial Data
5. Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March
6. CliniComp Announces Contract Wins With Daughters of Charity Health System
7. West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
8. MGC Diagnostics Corporation Announces Partnership with Frontera Strategies, LP
9. London Health Sciences Centre Announces Firsts in Treatment Option for Blood Circulation
10. BioElectronics Announces Publication of Patent Application
11. Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Period October – December 2016 ... to SEK -16.4 (-6.4) million Result after tax amounted to ... after dilution Cash flow from operating activities amounted to SEK ... Period full ... Operating result amounted to SEK -39.5 (-29.5) million ...
(Date:2/24/2017)... Mass. , Feb. 24, 2017  Today, ... US dental labs have a new path to ... using the Biodenta implant library integrated into exocad ... must implement FDA compliant Good Manufacturing Processes (GMP,s) ... manufacturer with Biodenta, and complete an audit process. Then, ...
(Date:2/24/2017)... Research and Markets has announced the addition ... Industry Forecast to 2025" report to their offering. ... The Global Wireless Health ... over the next decade to reach approximately $330.5 billion by 2025. ... for all the given segments on global as well as regional ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based ... and Palo Alto, is proud to announce an important upgrade to its geographic information ... home care close to home, and by having city-specific pages, NuevaCare is answering that ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... staffing, scheduling, and reporting for healthcare organizations. This comprehensive and customizable solution ... staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects critical ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure is ... specific LRRK2 mutation, according to a study released today at the 1st Pan ... a link between pesticides and incidence of sporadic PD through occupational exposure. This ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... tooth replacement options at his office, Antoine Dental Center. Currently, patients can get ... Some restrictions may apply, but patients can learn more about these offers by ...
(Date:2/24/2017)... ... 24, 2017 , ... An in-depth computational analysis of genetic variants implicated in ... eight genes that may explain why susceptibility to one of the disorders could place ... published today in the journal npj Schizophrenia. , “There is a wealth of ...
Breaking Medicine News(10 mins):